An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Enrolling by invitation · NCT01511393 · Registry updated 2023-06-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | Carcinoma, Medullary, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, medullary thyroid gland carcinoma, metabolic disease, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, type 2 diabetes mellitus | Enrolling by invitation | Not stated | 2023-06-13 | NCT01511393 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Eli Lilly and Company | 370 |
| Novo Nordisk A/S | 181 |
| United BioSource, LLC | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| United BioSource, LLC | Morgantown | United States | 1 |